Therapeutic angiogenesis for patients with limb ischemia by utilization of fibrin meshwork. Pilot randomized controlled study

International Angiology

Volumn 22, Issue 4, 2003, Pages 349-355

  Kipshidze, N ^a   Kipiani, K ^b   Beridze, N ^b   Roubin, G ^a   Tsapenko, M ^a   Shehzad, M Z ^a   Moses, J ^a   Kipshidze, N N ^c  

^a CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^b Natl Ctr of Angiol/Vasc Surgery   (Georgia)

^c Inst of Clin/Experimental Therapy   (Georgia)

Author keywords

Angiogenesis; Fibrin; Ischemia; Leg

Indexed keywords

ANGIOGENIC FACTOR; BASIC FIBROBLAST GROWTH FACTOR; COMPLEMENTARY DNA; DEFEROXAMINE; FIBRIN; FIBRINOGEN; FIBROBLAST GROWTH FACTOR 2; HYLAND IMMUNO; PLASMID DNA; SODIUM CHLORIDE; THROMBIN; VASCULOTROPIN;

ADULT; ANGIOGENESIS; ARTICLE; BELOW KNEE AMPUTATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG USE; FOLLOW UP; HUMAN; LIMB ISCHEMIA; MALE; OUTCOMES RESEARCH; PATIENT REFERRAL; RANDOMIZED CONTROLLED TRIAL; SYRINGE;

ADULT; DEFEROXAMINE; DRUG THERAPY, COMBINATION; FEASIBILITY STUDIES; FIBRIN; FIBRINOGEN; HUMANS; INJECTIONS, INTRAMUSCULAR; ISCHEMIA; MALE; MIDDLE AGED; NEOVASCULARIZATION, PHYSIOLOGIC; PILOT PROJECTS; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 1542285978     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Kannel WB, McGee DL. Update on some epidemiologic features of intermittent claudication: the Framingham study. J Am Geriatr Soc 1985;33:13-8.
2. Rutherford RB, Baker JD, Ernst C, Johnston KW, Porter JM, Ahn S et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg 1997;26:517-38.
3. Hiatt WR. Medical treatment of peripheral arterial disease and claudication. N Engl J Med 2001;344:1608-21.
4. Dormandy J, Mahir M, Ascady G, Balsano F, De Leeuw P, Blombery P et al. Fate of the patient with chronic leg ischemia. A review article. J Cardiovasc Surg (Torino) 1989;30:50-7.
5. Isner J, Rosenfield K. Redefining the treatment of peripheral artery disease. Circulation 1993;88:1534-57.
6. Gregg R. Bypass or amputation? Concomitant review of bypass arterial grafting and major amputations. Am J Surg 1985;149:397-402.
7. Ouriel K, Fiore W, Geary J. Limb threatening ischemia in the medically compromised patient: amputation or revascularization? Surgery 1988;104:667-72.
8. Graham A, Schniederman A, Jothy S, Homan J, Symes JF. Staged reversal of venous flow for revascularization of the severely ischemic limb. J Surg Res 1983;35:11-20.
9. Goldsmith H, Griffith A, Catsimpoolas N. Increased vascular perfusion after administration of an omental lipid fraction. Surg Gynecol Obstet 1986;162:579-83.
10. Pevec W, Hendricks D, Rosenthal M, Shestak KC, Steed DL, Webster MW. Revascularization of an ischemic limb by use of a muscle pedical flap: a rabbit model. J Vasc Surg 1991;13:385-90.
11. Folkman J, Shing Y. Angiogenesis. J Biol Chem 1992; 267:10931-4.
12. Mack C, Patel S, Schwarz E, Zanzonico P, Hahn RT, Ilercil A et al. Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart. J Thorac Cardiovasc Surg 1998; 115:168-77.
13. Shou M, Thirumurti V, Rajanayagam S, Lazarous DF, Hodge E, Stiber JA et al. Effect of basic fibroblast growth factor on myocardial angiogenesis in dogs with mature collateral vessels. J Am Coll Card 1997;29:1102-6.
14. Yanagisawa-Miwa A, Uchida Y, Nakamura F, Tomaru T, Kido H, Kamijo T et al. Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. Science 1992;257:1401-3.
15. Baffour R, Berman J, Garb J, Rhee SW, Kaufman J, Friedmann P. Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: dose-response effect of basic fibroblast growth factor. J Vasc Surg 1992;16:181-91.
16. Laham R, Leimbach M, Chronos N, Vansant JP, Pearlman JP, Pettigrew R et al. Intracoronary administration of recombinant fibroblast growth factor-2 (rFGF-2) in patients with severe coronary artery disease: results of Phase I [abstract]. J Am Coll Card 1999;33:383A.
17. Pu L, Sniderman A, Arekat Z, Graham AM, Brassard R, Symes JF. Angiogenic growth factor and revascularization of this ischemic limb: evaluation in a rabbit model. J Surg Res 1993;54:575-83.
18. 165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation 1995;91:2687-92.
19. Isner J, Walsh K, Symes J, Pieczek A, Takeshita S, Lowry J et al. Arterial gene therapy for therapeutic angiogenesis in patients with peripheral artery disease. Circulation 1995;91:2687-92.
20. 165 in patient with ischemic limb. Lancet 1996;348:370-40.
21. Isner JM, Baumgartner I, Rauh G, Schainfield R, Blair R, Manor O et al. Treatment of thromboangiitis obliterans by intramuscular gene transfer of vascular endothelial growth factor; preliminary clinical results. J Vasc Surg 1998;28:964-75.
22. Henry T, Annex BH, Azrin MA, McKendallGR, Willerson JT, Hendel RC et al. Double blind, placebo controlled trial of recombinant human vascular endothelial growth factor (RhVEGF): The VIVA Trial. J Am Coll Card 1999;33: 384A.
23. Henry TD, Annex BH, McKendall GR, Azrin MA, Lopez JJ, Giordano FJ et al. The VIVA trial: vascular endothelial growth factor in ischemia for vascular angiogenesis. Circulation 2003;107:1359-65.
24. Kipshidze N, Chekanov V, Kappes S, Abdurahman A, Hammen D, Chawla PS et al. Therapeutic angio-genesis for critical limb ischemia to limit or avoid amputation. J Invas Cardiol 1999;11:25-8.
25. Chekanov V, Nikolaychik V, Tchekanov G. The use of biological glue for better adhesions between the skeletal muscle flap and the myocardium and for increasing capillary ingrowth. J Thorac Cardiovasc Surg 1996;111:678-80.
26. Chekanov VS, Tchekanov GV, Rieder MA, Eisenstein R, Wankowski DM, Schmidt DH et al. Biologic glue increases capillary growth after cardiomyoplasty in an ischemic cardiomyopathy model. ASAIO J 1996;42:M480-7.
27. Kabuto M, Kubota T, Kobayashi H, Nakagawa T, Arai Y, Kitai R. Experimental study of intraoperative local chemotherapy with fibrin glue containing nitrosourea for malignant gliomas. Surg Neurol 1995;44:151-7.
28. Lasa C Jr, Hollinger J, Drohan W, MacPhee M. Delivery of demineralized bone powder by fibrin sealant. Plast Reconstr Surg 1995;96:1409-18.
29. Fasol R, Schumacher B, Schlaudraff K, Hauenstein KH, Seitelberger R. Experimental use of a modified fibrin glue to induce site-directed angiogenesis from the aorta to the heart. J Thorac Cardiovasc Surg 1994;107:1432-9.
30. Dvorak HF, Harvey VS, Estrella P, Brown LF, McDonagh J, Dvorak AM. Fibrin containing cells induce angiogenesis. Lab Invest 1987;57:673-82.
31. Lederman RJ, Mendelsohn FO, Anderson RD, Saucedo JF, Tenaglia AN, Hermiller JB et al. Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomized trial. Lancet 2002;359:2053-8.
32. Yamakawa R, Ishii M, Sugimura T, Akagi T, Eto G, Iemura M et al. Coronary endothelial dysfunction after Kawasaki disease: evaluation by intracoronary injection of acetylcholine. J Am Coll Card 1998;31:1074-80.
33. Deyerling W, Haverich A, Potel J, Hetzer R. A suspension of fibrin glue and antibiotic for local treatment of mycotic aneurism in endocarditis: an experimental study. Thorac Cardiovasc Surg 1984;32:369-72.
34. Haverich A, Hirt S, Karck M, Siclari F, Wahlig H. Prevention of graft infection by bonding of gentamycin to Dacron protheses. J Vasc Surg 1992;15:187-93.
35. Kan SS, Gosselin C, Ren D, Greisler H. Selective stimulation of endothelial cell proliferation with inhibition of smooth muscle cell proliferation by fibroblast growth factors plus heparin delivered from fibrin glue suspensions. Surgery 1995;118:280-7.
36. Sakiyama-Elbert SE, Hubbell JA. Controlled release of nerve growth factor from a heparin-containing fibrin-based cell ingrowth matrix. J Control Release 2000;69:149-58.
37. Beerepoot L, Shima D, Kuroki M, Yeo KT, Voest EE. Upregulation of vascular endothelial growth factor production by iron chelators. Cancer Res 1996;56:3747-51.
38. Campbell W, Johnston J, Kernick V, Rutter EA. Lower limb amputation; striking the balance. Ann Rev Coll Surg 1994:76:205-9.
39. Dawson F, Keller D, Brand R, Pesch-Batenburg J, Hajo van Bockel J. Late outcomes of limb loss affer failed infrainguinal bypass. J Vasc Surg 1995;21:613-22.
40. Skinner G, Cohen A. Amputation for premature peripheral atherosclerosis: do young patients do better? Lancet 1956;348:1896.
41. Taylor L Jr, Porter J. Natural history and nonoperative treatment of chronic lower extremity ischemia. In: Rutherford R, editor. Vascular surgery. Philadelphia: WB Saunders; 1995.p.751-66.
42. Losordo DW, Vale PR, Hendel RC, Milliken CE, Fortuin FD, Cummings N et al. Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia. Circulation 2002;105:2012-8.
43. Laham RJ, Sellke FW, Edelman ER, Pearlman JD, Ware JA, Brown DL et al. Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: results of a phase I randomized, double-blind, placebo-controlled trial. Circulation 1999;100:1865-71.
44. Tateishi-Yuyama E, Matsubara H, Murohara T, Ikeda U, Shintani S, Masaki H et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomized controlled trial. Lancet 2002;360:427-35.
45. Lasarous DF, Unger EF, Epstein SE, Stine A. Effect of basic fibroblast growth factor on lower extremity blood flow in patients with intermittent claudication; preliminary results [abstract]. Circulation 1998;98 Suppl 1:645-50.
46. Laube HR, Felix F, Aurisch A, Redlin T, Konertz W. Indirect revascularization of ischemic myocardium with human recombinant basic fibroblast growth factor (bFGF): first clinical results (Personal communication).
47. Robinson GA, Madison RD. Survival of adult rat retinal ganglion cells with regrown axons in peripheral nerve grafts: a comparison of graft attachment with suture of fibrin glue. J Neurosurg 2000;93:275-8.
48. Banai S, Jaklitsch M, Casscells W, Shou M, Shrivastav S, Correa R et al. Effects of acidic fibroblast growth factor on normal and ischemic myocardium. Circ Res 1991; 69:76-85.
49. Varani J, Dame M, Diaz M, Stoolman L. Deferoxamine interferes with adhesive functions of activated human neutrophils. Shock 1996;5:395-402.